Skip to content

Intervention trial of asthmatic cough therapy

Intervention trial of asthmatic cough therapy - INTACT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001023
Enrollment
180
Registered
2011-03-01
Start date
2007-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cough variant asthma

Interventions

leukotriene receptor antagonist inhaled corticosteroids

Sponsors

Japanese cough variant asthma research society
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The outpatient with cough variant asthma and whose symptom was controlled by initial treatment within three months.

Exclusion criteria

Exclusion criteria: The patient with typical asthma. The patient with atopic cough. The patient with sinobronchial syndrome. The patient with severe respiratory diseases. The patient who is taking angiotensin-converting enzyme inhibitor. The patient who has past history of serious adverse effect or allergy against leukotriene receptor antagonist or inhaled corticosteroids. The case that the doctor judged the patient who dose not suit to the subject of the present study.

Design outcomes

Primary

MeasureTime frame
The onset of typical asthma for one year in patient with cough variant asthma.

Countries

Japan

Contacts

Public ContactMasaki Fujimura

Kanazawa University Graduate School of Medical Science, Japan Respiratory Medicine, Cellular Transplantation Biology

fujimura@med3.m.kanazawa-u.ac.jp076-265-2271

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026